Laucevičius Aleksandras, Ryliškytė Ligita, Balsytė Jūratė, Badarienė Jolita, Puronaitė Roma, Navickas Rokas, Solovjova Svetlana
Vilnius University Hospital Santariškių Klinikos, Santariškių 2, 08661 Vilnius, Lithuania; Faculty of Medicine, Vilnius University, M.K. Čiurlionio, 03101 Vilnius, Lithuania.
Vilnius University Hospital Santariškių Klinikos, Santariškių 2, 08661 Vilnius, Lithuania; Faculty of Medicine, Vilnius University, M.K. Čiurlionio, 03101 Vilnius, Lithuania.
Medicina (Kaunas). 2015;51(3):152-158. doi: 10.1016/j.medici.2015.05.001. Epub 2015 Jun 16.
We aimed to investigate the association between arterial stiffness assessed as cardio-ankle vascular index (CAVI) and cardiovascular (CV) risk factors and CV events in the middle-aged metabolic syndrome (MS) patients.
A follow-up study was carried out in 2106 middle-aged (53.83±6.17 years old, 62% women) MS subjects without overt atherosclerotic disease. Patients were initially recruited in 2009-2011 as participants of the Lithuanian High Cardiovascular Risk (LitHiR) primary prevention program and followed up for 3.8±1.7 years for CV events. Thorough cardiometabolic risk assessment was carried out at inclusion.
Subjects with higher CAVI had worse lipid and glucose metabolism profile: elevated total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C), decreased high-density lipoprotein cholesterol (HDL-C), higher fasting and oral glucose tolerance test (OGTT) glucose levels (all P<0.001), and lower fasting insulin (P=0.021). Greater age (P<0.001), heart rate (P=0.016), and mean arterial pressure (P<0.001) were also associated with higher CAVI. Over the follow-up period, 93 (4.4%) patients developed a cardiovascular event: 55 (2.6%) patients had myocardial infarction and 38 (1.8%) suffered a cerebrovascular event. Fatal CV events comprised 6.5% (n=6) of all CV events. CAVI was statistically significantly associated with occurrence of myocardial infarction (P=0.027) and total cardiovascular events (P=0.045), but not cerebrovascular events (P=0.65). However, this association was dependent on age and gender.
In the middle-aged MS patients, higher CAVI was associated with altered lipid and glucose metabolism, older age, greater heart rate and mean arterial pressure, and worse cardiovascular outcome.
我们旨在研究以心踝血管指数(CAVI)评估的动脉僵硬度与中年代谢综合征(MS)患者心血管(CV)危险因素及CV事件之间的关联。
对2106例无明显动脉粥样硬化疾病的中年(53.83±6.17岁,62%为女性)MS受试者进行了一项随访研究。这些患者最初于2009年至2011年作为立陶宛高心血管风险(LitHiR)一级预防项目的参与者被招募,并对CV事件进行了3.8±1.7年的随访。纳入时进行了全面的心脏代谢风险评估。
CAVI较高的受试者脂质和葡萄糖代谢状况较差:总胆固醇(TC)和低密度脂蛋白胆固醇(LDL-C)升高,高密度脂蛋白胆固醇(HDL-C)降低,空腹及口服葡萄糖耐量试验(OGTT)血糖水平较高(均P<0.001),空腹胰岛素较低(P=0.021)。年龄较大(P<0.001)、心率(P=0.016)和平均动脉压(P<0.001)也与较高的CAVI相关。在随访期间,93例(4.4%)患者发生了心血管事件:55例(2.6%)患者发生心肌梗死,38例(1.8%)患者发生脑血管事件。致命性CV事件占所有CV事件的6.5%(n=6)。CAVI与心肌梗死的发生(P=0.027)和总心血管事件(P=0.045)在统计学上显著相关,但与脑血管事件无关(P=0.65)。然而,这种关联取决于年龄和性别。
在中年MS患者中,较高的CAVI与脂质和葡萄糖代谢改变、年龄较大、心率和平均动脉压较高以及较差的心血管结局相关。